Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Labopharm, a developer of novel polymeric, nano-delivery systems for delivery of water-insoluble and poorly bio-available drugs, has named Mark D'Souza, the current chief financial officer of the company, as the new president and CEO.
Subscribe to our email newsletter
D’Souza replaces James Howard-Tripp as president and CEO.
Labopharm said the board of directors of the organization in conjunction with the management has undertaken a complete review of the business including consideration of all available strategic options.
Labopharm chairman Santo Costa said they are delighted to have Mark’s knowledge and experience to lead the Corporation forward.
"We are very grateful to Jim for his efforts on behalf of the Corporation over the last eleven (11) years," Costa said.